Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sars-cov-2 vaccine inactivated vero cell
- Development stage
- Phase 3
- Lead developer
- Sinovac Biotech
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
SARS-CoV-2 vaccine inactivated, Vero cell is an inactivated whole-virus COVID-19 vaccine produced using the Vero cell line derived from African green monkey kidney cells. The virus (typically CZ02 or 19nCoV-CDC-Tan-HB02 strain) is cultured on Vero cells, harvested, and then chemically inactivated (commonly with β-propiolactone). The resulting viral particles are purified and adsorbed onto aluminum hydroxide as an adjuvant. This formulation stimulates the immune system to produce neutralizing antibodies against SARS-CoV-2 without causing disease. It is indicated for active immunization to prevent COVID-19 and has been widely used globally under various brand names such as CoronaVac (Sinovac) and Covilo (Sinopharm). The primary indication is prevention of COVID-19 infection[1][2][3].
- Brand names
- CoronaVac
- Other names
- covid-19 vaccine vero cell inactivatedcovid19 vaccine vero cell inactivatedcovid 19 vaccine vero cell inactivatedcoviloxinxing guanzhuang bingdu miehuoyimiao vero xibao
Beyond the preview
Go deeper on sars-cov-2 vaccine inactivated vero cell.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sars-cov-2 vaccine inactivated vero cell.